Drug Designing: Open Access
Open Access

Drug Design in the Context of the Neurodegenerative diseases

Drug Design in the Context of the Neurodegenerative diseases

The brain is an extremely complex organ with vast numbers of pathways that allow us to do the amazing things that we do. Neurodegenerative Diseases are Brain illness that causes neurons to die and the brain to shrink. People all over the world are suffering from neurodegenerative diseases, which are illnesses that lead to cell death in the brain.

Acknowledging the current situation regarding Neurodegenerative Diseases Research, Drug Designing: Open Access Journal is coming up with a special issue titled: “Drug Design in the Context of the Neurodegenerative diseases” which has been edited by Dr. Gjumrakch Aliev.

Dr. Gjumrakch Aliev is the President and CEO of GALLY International Biomedical Research Consulting LLC, San Antonio, USA. He has a vast scope and experience on Biomedical Research.

We warmly and enthusiastically invite the eminent researchers to take part in this special issue to enhance recent advancements in Neuroresearch.

We encourage submission of research articles, review articles, short communication, mini-review, case reports, editorial, etc. through email at ddo[at]jpeerreview[dot]org

Submissions are accepted from November 20^th, 2020.

Submissions are accepted till December 21^th, 2020